Companies similar to CHINA CAR-T CELL
Sign up to Download

1-30 of 6,524,417 results

  • chinacartcell.com
  • 3
  • 1
Albert on The cost of CAR-T preparation in China is much cheaper than in the USA... CAR-T cell therapy or Chimeric antigen receptorTcell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing..
Relevance: 46.206955
  • www.aurora-biopharma.com
  • 1
  • 2
  • 13
Aurora Biopharma is founded on a single mission to revolutionize the treatment of cancer, by using the human body's immune system. Aurora is developing state-of-the-art cancer immunotherapy, a form of adoptive cell transfer called Chimeric Antigen..
Relevance: 44.472744
  • jabious.com
  • 1
  • 2
JA Bio is a startup bio-tech company located at Cambridge in Massachusetts. We are focusing on anti-cancer cell immune therapeutics discovery and development. Our research includes,... Based on NBRL (nbrm.org) developed immune cell therapy, JA Bio..
Relevance: 43.012466
  • cytoart.com
  • 2
  • 1
Cytoart is a biotechnology company aimed at improving the development, quality control and clinical monitoring of CAR T-cell therapies. By offering our comprehensive anti-idiotypic platform, we are a leading provider of companion diagnostics for CAR..
Relevance: 40.833252
  • wugen.com
  • 2
  • 23
Our cell therapy products originate from healthy donors and are further manipulated in order to enhance their function to eliminate cancer cells. Our NK cell and CAR-T immuno-oncology therapies address the needs of patients with solid tumors, acute..
Relevance: 40.675213
  • triumvira.com
  • 1
  • 6
  • 12
Triumvira is developing unique, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat a broad range of patients with cancer... Our partners have independently validated our technology in..
Relevance: 40.65371
  • www.famicordtx.com
  • 1
  • 3
  • 1
FamiCordTx is a company established to implement cell engineering therapies. Our main goal is to implement therapy based on CAR-T (chimeric antigen receptor) technology, i.e. genetically modified T-cells used for blood neoplasm treatment.wi...
Relevance: 39.849968
  • www.dynamiccelltherapies.com
  • 1
  • 1
Dynamic Cell Therapies is developing controllable CAR T cells to address difficult-to-treat cancers. Our platform technology of dynamic control of engineered T cells will improve the safety, efficacy, and durability of CAR T cell therapies. This..
Relevance: 39.54856
  • genomefrontier.com
  • 1
  • 1
  • 5
Using the Quantum Engine™, GenomeFrontier is developing multiple cell modified gene therapy products, including chimeric antigen receptor T (CAR-T) and T cell receptor T (TCR-T) therapies. These are live, cell-based "drugs" composed of immune cells..
Relevance: 37.71279
  • www.fresenius.com
  • 32
  • 31
  • 42
Interview with Prof. Iwasaki, winner of the Else Kröner Fresenius Prize for Medical Research 2023, endowed with 2... CAR T cell therapy: Innovative therapy with the aid of genetically modified cells... How artificial intelligence helps to detect..
Relevance: 37.274868
  • tailored-therapeutics.com
  • 1
TAILORED THERAPEUTICS is an innovative cell therapy company focused on development of cancer treatments sourced from a patient's own immune system cells. TAILORED THERAPEUTICS has developed a portfolio of products based on tumor infiltrating..
Relevance: 36.358448
  • www.glycostem.com
  • 2
  • 1
  • 15
Glycostem is developing a pipeline of cellular immunotherapy therapies, which has the potential to redefine standards of care across various type of cancer. Besides of oNKord® as our lead investigational product, we are developing viveNK TM, Chimeric..
Relevance: 36.29712
  • www.cell-easy.com
  • 1
  • 1
  • 8
Cell-Easy is offering a step-by-step and de-risking partnership approach, guiding you to the optimal path for achieving First In Human access while prioritizing both Timelines and Budget... Analytics-driven Contract Development and Manufacturing..
Relevance: 36.141518
  • www.jin-lab.org
  • 2
  • 1
Our interest is in developing molecules and cells for imaging and therapy applications. Essential to this effort is the use of molecular and cellular engineering, built on complementary use rational design and directed evolution approaches. Specific..
Relevance: 36.132183
  • www.genecellbt.com
  • 1
  • 5
  • 1
GeneCELL BT is dedicated to the cure of cancer and autoimmune diseases through the use of immune cell therapies, CAR-T, CAR-NK and CAR-Macrophage... We have focused initially on CAR-T treatment therapies because T cells are the most powerful cells..
Relevance: 35.798805
  • www.biontech.com
  • 3
  • 3
  • 13
We aim to bring novel oncology and infectious disease therapies to the market. BioNTech is also exploring how to apply its technology to advancements in treating allergies, inflammatory diseases, and regenerative medicine... BioNTech is a fully..
Relevance: 35.213062
  • kyvernatx.com
  • 7
  • 1
  • 19
Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases... Kyverna is pioneering CAR T-cell therapies for autoimmune disease patients by harnessing..
Relevance: 34.998608
  • www.haemalogix.com
  • 1
  • 13
HaemaLogiX is researching immune based treatments (Monoclonal Antibodies, CAR T cell therapies and Bispecific antibodies) that target unique antigens on malignant cells to treat patients suffering from blood cancers (Multiple Myeloma) and other life-..
Relevance: 34.884842
  • tcbiopharm.com
  • 4
  • 1
  • 7
TC BioPharm (TCBP) is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious..
Relevance: 34.73941
  • www.axistherapeutics.com
  • 1
  • 14
Axis Therapeutics is a leading cancer immunotherapy company focused on the development of T cell therapies... Axis Therapeutics is developing cell-based therapies that take advantage of the unique attributes of TCR mediated target recognition...
Relevance: 34.728493
  • www.cyteph.bio
  • 2
  • 1
  • 6
Cyteph is an Australian biotechnology company developing off-the-shelf T cell and CAR T cell therapies, harnessing the power of the immune system to target and destroy solid tumours... Cyteph is a spin-out company from QIMR Berghofer Medical..
Relevance: 34.640793
  • pancancer-t.com
  • 1
  • 13
Pan Cancer T is an immunotherapy company developing next-generation TCR-T cell therapies for solid cancer... TCR-T therapy is based on genetically modified T cells directed against specific targets on tumor cells. Pan Cancer T´s differentiated Next..
Relevance: 34.30046
  • celularity.com
  • 24
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent..
Relevance: 33.937843
  • syncromune.com
  • 3
  • 16
Syncromune™ is developing SYNC-T™, a disruptive platform immunotherapy designed to optimize T cells and the immune system to attack cancer throughout the body... The SYNC-T solid tumor therapy platform is personalized and performed in situ (within..
Relevance: 33.604927
  • verismotherapeutics.com
  • 2
  • 13
Verismo Therapeutics is pioneering CAR T-cell therapy for the treatment of solid tumors. This paradigm-shifting technology features a unique KIR-CAR construct that has been proven to reduce T-cell exhaustion and kill solid tumor models in in vivo..
Relevance: 33.582756
  • www.medrego.com
  • 3
  • 3
  • 5
Medrego is a leading producer of regenerative medicine, stem cell therapy, and gut health solutions in the region... Medrego is NORTHERN Europe's leading producer of regenerative medicine solutions and animal stem cell therapy... Medrego team is an..
Relevance: 33.469635
  • minktherapeutics.com
  • 1
  • 1
  • 6
MiNK Therapeutics is a clinical-stage precision oncology company developing allogeneic, invariant natural killer T cell therapies for cancer and other immune-mediated diseases. The lead product is an off-the-shelf, cell therapy based on a targeted..
Relevance: 33.461155
  • www.carsgen.com
  • 3
  • 9
CARsgen is a biopharmaceutical company with operations in China and the U.S. and is focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. The Company has built an integrated cell therapy platform..
Relevance: 33.381557
  • www.sasmocongress2022.co.za
  • 4
  • 6
  • 2
The South African Society of Medical Oncology (SASMO) and The South African Stem Cell Transplant Society (SASCeTS) invite you to attend the Joint 2022 Congress which will be held at the Sandton Convention Centre 06 - 08 May 2022... An increasing..
Relevance: 33.085613
  • catamaranbio.com
  • 2
  • 1
  • 20
We are driven to realize the full potential of cell therapy by powering a key type of immune cell, Natural Killer (NK) cells, with new properties to create transformative cancer treatments for more patients. Using synthetic biology and non-viral cell..
Relevance: 32.855064